Literature DB >> 33563143

Strengths-based behavioral telehealth with sexual and gender diverse clients at Center on Halsted.

Ing Swenson1, Trevor G Gates2, Michael P Dentato3, Brian L Kelly3.   

Abstract

The COVID-19 pandemic necessitated an immediate response and rapid transition from traditional face-to-face behavioral health services to behavioral telehealth at an organization serving sexual and gender diverse (SGD) individuals in Chicago. In this practice innovations article, we explore the unfolding public health crisis and the impact on service delivery for SGD individuals. Using a large multi-service organization as a case study, this paper describes how key members of the staff and leadership team shifted services online as a means of responding to isolation, loneliness, and disparities in access to healthcare for Chicago SGD communities. Lessons learned and practice recommendations are presented.

Entities:  

Keywords:  Sexual and gender diversity; behavioral health; bisexual; counseling; gay; lesbian; queer; telehealth; telemedicine; transgender

Mesh:

Year:  2021        PMID: 33563143     DOI: 10.1080/00981389.2021.1885561

Source DB:  PubMed          Journal:  Soc Work Health Care        ISSN: 0098-1389


  3 in total

Review 1.  Addressing the Behavioral Health Needs of Sexual and Gender Minorities During the COVID-19 Pandemic: a Review of the Expanding Role of Digital Health Technologies.

Authors:  Emile Whaibeh; Emily L Vogt; Hossam Mahmoud
Journal:  Curr Psychiatry Rep       Date:  2022-07-16       Impact factor: 8.081

Review 2.  Telehealth in Trans and Gender Diverse Communities: the Impact of COVID-19.

Authors:  Laura J Mintz; Braveheart Gillani; Scott E Moore
Journal:  Curr Obstet Gynecol Rep       Date:  2022-04-19

Review 3.  Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations - Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine.

Authors:  E Rousseau; R F Julies; N Madubela; S Kassim
Journal:  Curr HIV/AIDS Rep       Date:  2021-10-27       Impact factor: 5.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.